한글목차

세계의 생체 임플란트 시장은 2024년 85억 4,000만 달러에서 2030년까지 124억 2,000만 달러로, CAGR 6.44%로 확대될 전망입니다.

생체 임플란트란 생체적합성 물질을 이용하여 생체 기능을 대체, 보조, 강화하기 위해 체내 또는 체표에 삽입하는 의료기기를 말합니다. 시장 확대는 기본적으로 세계 인구의 고령화에 따른 수복 시술에 대한 수요 증가와 심혈관질환 및 골관절염과 같은 만성질환의 유병률 증가에 의해 주도되고 있습니다.

주요 시장 촉진요인

생체 재료 및 제조 기술의 기술적 발전은 생물학적 임플란트의 능력을 근본적으로 재구성하여 우수한 통합성, 내구성 및 환자별 솔루션을 제공하는 제품을 만들어 내고 있습니다. 새로운 고분자 및 표면 개질 금속을 포함한 첨단 생체재료에 대한 지속적인 연구는 생체적합성과 기능성을 향상시켜 부작용을 줄이고 임플란트 성능을 개선할 수 있습니다.

주요 시장 과제

복잡하고 종종 장기화되는 규제 승인 절차는 세계 바이오 임플란트 시장 확대에 큰 장벽으로 작용하고 있습니다. 이러한 까다로운 요구사항은 제조업체에 막대한 재정적 부담을 주며, 개발 기간을 연장시키는 요인으로 작용하고 있습니다.

주요 시장 동향

주요 동향으로 재생의료용 생체 임플란트에 대한 관심이 높아지고 있습니다. 이는 단순한 기계적 치환을 넘어 생물학적 메커니즘을 통해 손상된 조직과 장기를 복구, 대체, 재생하는 것을 목적으로 합니다. 특히, 첨단 생체재료와 세포 성분 및 성장인자를 통합한 임플란트를 개발하여 신체의 자연 치유 과정을 적극적으로 촉진하기 위한 노력이 진행되고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 생체 임플란트 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(자가이식, 동종이식, 이종이식)
  • 용도별(심혈관 임플란트, 정형외과 임플란트, 기타 연조직 임플란트)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 생체 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 생체 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 생체 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 생체 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 생체 임플란트 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 생체 임플란트 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Integra LifeSciences Corporation
• NuVasive, Inc.
• Edwards Lifesciences Corporation
• Stryker Corp.
• LifeCell International Pvt. Ltd.
• Medtronic Plc
• Osteotec Limited
• BioPolymer GmbH & Co KG
• Johnson & Johnson Services, Inc
• Baxter International Inc.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Biological Implants Market will grow from USD 8.54 Billion in 2024 to USD 12.42 Billion by 2030 at a 6.44% CAGR. Biological implants are medical devices placed inside or on the body to replace, support, or enhance biological functions, utilizing biocompatible materials. The market's expansion is fundamentally driven by an aging global population requiring a greater number of restorative procedures, coupled with the increasing prevalence of chronic diseases such as cardiovascular conditions and osteoarthritis.

Key Market Drivers

Technological advancements in biomaterials and manufacturing fundamentally reshape the capabilities of biological implants, leading to products that offer superior integration, longevity, and patient-specific solutions. Ongoing research in advanced biomaterials, including novel polymers and surface-modified metals, enhances biocompatibility and functionality, thereby reducing adverse reactions and improving implant performance. Advanced manufacturing techniques, particularly 3D printing, enable the creation of highly customized implants with intricate designs that closely mimic natural biological structures, fostering better osseointegration and tissue regeneration.

Key Market Challenges

The complex and often prolonged regulatory approval processes represent a significant impediment to the expansion of the global biological implants market. These stringent requirements impose substantial financial burdens and extend development timelines for manufacturers. The necessity to adhere to evolving regulations, particularly evident in regions with advanced regulatory frameworks, escalates costs associated with clinical evaluations, post-market surveillance, and certification. This increased regulatory load directly curtails manufacturers' ability to allocate resources to research and development of novel biological implants.

Key Market Trends

A key trend is the increased focus on regenerative bio-implants, which aim to restore, replace, or regenerate damaged tissues and organs through biological mechanisms, moving beyond mere mechanical replacement. This involves developing implants that integrate advanced biomaterials with cellular components or growth factors to actively stimulate the body's natural healing processes. For instance, REGENXBIO Inc. and Nippon Shinyaku Co., Ltd. announced a strategic partnership in January 2025 for the development and commercialization of gene therapies, with REGENXBIO receiving $110 million upfront and up to an additional $700 million in potential milestones. This significant investment, as reported by Contract Pharma, January 15, 2025, in "Regenxbio, Nippon Shinyaku Partner for MPS II, MPS I Gene Therapies," highlights the market's trajectory towards biological solutions that foster genuine tissue regeneration.

Key Market Players

• Integra LifeSciences Corporation
• NuVasive, Inc.
• Edwards Lifesciences Corporation
• Stryker Corp.
• LifeCell International Pvt. Ltd.
• Medtronic Plc
• Osteotec Limited
• BioPolymer GmbH & Co KG
• Johnson & Johnson Services, Inc
• Baxter International Inc.

Report Scope:

In this report, the Global Biological Implants Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Implants Market, By Product:

• Autografts
• Allografts
• Xenografts

Biological Implants Market, By Application:

• Cardiovascular Implants
• Orthopedic Implants
• Others Soft Tissue Implants

Biological Implants Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Implants Market.

Available Customizations:

Global Biological Implants Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Implants Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Autografts, Allografts, Xenografts)
  • 5.2.2. By Application (Cardiovascular Implants, Orthopedic Implants, Others Soft Tissue Implants)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Biological Implants Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Biological Implants Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Biological Implants Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Biological Implants Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Biological Implants Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Biological Implants Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Biological Implants Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Biological Implants Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Biological Implants Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Biological Implants Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Biological Implants Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Biological Implants Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Biological Implants Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Biological Implants Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Biological Implants Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Biological Implants Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Biological Implants Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Biological Implants Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Biological Implants Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Biological Implants Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Biological Implants Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Biological Implants Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Biological Implants Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Biological Implants Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Biological Implants Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Integra LifeSciences Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. NuVasive, Inc.
• 15.3. Edwards Lifesciences Corporation
• 15.4. Stryker Corp.
• 15.5. LifeCell International Pvt. Ltd.
• 15.6. Medtronic Plc
• 15.7. Osteotec Limited
• 15.8. BioPolymer GmbH & Co KG
• 15.9. Johnson & Johnson Services, Inc
• 15.10. Baxter International Inc.

16. Strategic Recommendations

17. About Us & Disclaimer